Trump puts RFK Jr, railed against a vaccine ‘holocaust’, in charge of vaccine safety
Kennedy said the purpose would be ‘to make sure we have scientific integrity in the vaccine process for efficacy and safety effects’
Jan 11, 2017 by Daily Mail
President-elect Donald Trump has tapped a Kennedy – and a vaccine skeptic – to run a new commission on the safety of vaccines.
Robert F. Kennedy Jr. revealed his new role after a meeting at Trump Tower on Tuesday.
He said Trump had asked him to head a commission on ‘vaccine safety and scientific integrity’ and that he had agreed to do so.
Both Trump and Kennedy have have raised suspicions about vaccines despite their overwhelming support among scientists and physicians as a way to prevent the spread of deadly diseases that can infect infants and other children when the pool of protected people is diminished.
Kennedy said the purpose would be ‘to make sure we have scientific integrity in the vaccine process for efficacy and safety effects.’
The vaccine skeptic is the most prominent Democrat to accept an assignment from President-elect Trump
Trump tweeted about the unproven link between vaccines and autism in 2014
Trump in 2012 went after ‘massive doses’ in vaccines
BERNIE SANDERS PRAISES TRUMP PROMISE TO TAKE ON BIG PHARMA
Senator shares goal to reform behemoth drug industry
Jan 12, 2017 by RT
President-elect Donald Trump and former presidential candidate Senator Bernie Sanders don’t always see eye to eye, but the democratic socialist is praising Trump’s recent comments on the pharmaceutical industry in hopes of achieving reform.
While most remember Trump’s Wednesday news conference for the unfortunate back-and-forth with CNN’s Jim Acosta, it was a different moment that piqued Sanders’ interest.
“Our drug industry has been disastrous,” Trump told reporters, first stressing that they needed to up manufacturing of drugs in the US.
“And the other thing we have to do,” Trump continued, “is create new bidding procedures for the drug industry, because they’re getting away with murder.”
Sanders largely agrees.
“He’s right,” Sanders said in an interview with the Huffington Post. “And I’ve been saying that for years.”
“Pharma does get away with murder. Literally murder. People die because they can’t get the prescription drugs they need,” the former Democratic presidential candidate said.
“Sometimes he copies my statements,” Sanders said of Trump. “I don’t know if he got that one from me.”
Both Trump and Sanders seem to share a tendency for overstatements, however. Sanders also agreed with Trump’s comments about big pharma lobbyists, telling the Post, “It’s true. Pharma does have lobbyists all over the country, not just in Washington. These people are horrific.”
Sanders also corrected Trump on the matter of “bidding.”
He means ‘negotiating,’” Sanders said. “And if he’s up for negotiating, of course we have to do that. The VA does that and their prices are lower than for Medicare and other government agencies.”
The Huffington Post reported that Sanders would introduce a nonbinding amendment to budgetary legislation Wednesday evening, which would allow prescription drugs to be imported from highly regulated foreign markets, including Canada and the United Kingdom. Sanders believes those countries’ negotiations with the industry would ultimately save the US money as well.
However, Sanders does not seem optimistic.
“The question is whether Trump and his Republican colleagues have the guts to take on one of the most powerful industries in America,” Sanders said. “It’s not gonna be done, of course.”
Sanders has been highlighting Trump’s past and current positions on healthcare and entitlements for some time. On Tuesday, a day before Trump’s first press conference as president-elect, Sanders tweeted about Trump 18 times.
Draining the Pharma swamp: Donald Trump announces plan to hammer Big Pharma’s monopoly profits by requiring competitive bidding for government drug purchase contracts
January 11, 2017 by: Mike Adams
(NaturalNews) In a welcome announcement during a press conference today, President-elect Donald Trump announced a plan to shatter the monopolistic pricing of Big Pharma that has been draining literally trillions of dollars from the government for the past two decades.
“Pharma has a lot of lobbyists and a lot of power,” said Trump. “There’s very little bidding on drugs. We’re the largest drug buyer in the world, and we’re going to start bidding. We’re going to start saving billions of dollars on drugs.” (RELATED: See more coverage of President Trump at Trump.news)
Trump is referencing the fact that all the former Presidents in recent memory — Clinton, Bush and Obama — have maintained what can only be called a “monopoly pricing drug cartel” in the United States, where the U.S. government pays outrageously high prices for prescription medications purchased via Medicare, federal health coverage plans and VA Hospital operations. The utter lack of competitive pricing has been kept in place by an army of pharma lobbyists “bribing” complicit lawmakers and bureaucrats to keep high prices in place and eliminate competitive bidding for prescription medication purchase contracts. (RELATED: See daily coverage of medicine news at Medicine.news)
$324.6 billion a year in overpriced prescription medications to appease Big Pharma lobbyists
As a result, the federal government is spending hundreds of billions of dollars on overpriced prescription drugs each year, dolling out a whopping $324.6 billion on prescription drugs in 2015 alone. “Spending on prescription drugs outpaced all other services in 2015,” says a Centers for Medicare and Medicaid report entitled National Health Expenditures: 2015 Highlights.
That same report reveals that U.S. health care spending has now reached $3.2 trillion annually, or nearly $10,000 per person. If this spending isn’t curtailed, it’s going to bankrupt America and will soon hit an astonishing 25% of GDP, meaning 1 out of every 4 dollars generated in the entire U.S. economy will be going to drug companies, cancer treatment centers, hospitals, doctors and medical device manufacturers.
High drug prices weaken U.S. worker competitiveness in global marketplace
Obviously, that rate of expenditure is unsustainable. It also makes U.S. workers far more expensive than workers in overseas regions, harming the economic competitiveness of U.S. companies. In order for U.S. workers to remain competitive, U.S. health care costs need to be drastically reduced… and that means finally forcing drug companies to compete on pricing rather than receiving “full retail” monopoly-priced reimbursements from the federal government.
Making America Great Again, in other words, means stopping the federal government from being ripped off by Big Pharma.
Notably, Hillary Clinton’s campaign accepted millions of dollars from Big Pharma sources, and there’s little question that Clinton, if she had won the election, would have maintained the status quo of monopoly prices. See “Hillary Clinton will not challenge FDA Monopoly” and “If you support Hillary Clinton, you support big pharma and mandatory vaccinations.” (RELATED: Find more news on Hillary Clinton at Clinton.news)
In contrast, Donald Trump is genuinely “draining the swamp” by eliminating waste, fraud and abuse across many sectors of the federal government. Big Pharma just got served: The era of easy profits and a compliant federal government writing unlimited fat checks is now coming to an end.
Every American fed up with unaffordable drug prices, outrageous health insurance premiums and the corruption and influence of lobbyists in Washington D.C. should applaud this announcement by Trump.
You can find many posts about the dangers of vaccines and Big Pharma by searching this blog